Back to Search
Start Over
Lipella Pharmaceuticals reveals top line results of Phase 2a clinical trial of LP-10 for Haemorrhagic Cystitis
- Source :
- M2 EquityBites (EQB). January 12, 2023
- Publication Year :
- 2023
-
Abstract
- M2 EQUITYBITES-January 12, 2023-Lipella Pharmaceuticals reveals top line results of Phase 2a clinical trial of LP-10 for Haemorrhagic Cystitis (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a US-based [...]
- Subjects :
- Cystitis
Clinical trials
Business
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 EquityBites (EQB)
- Publication Type :
- News
- Accession number :
- edsgcl.732974483